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Randomised controlled trials (RCTs) have shown the efficacy of CBTp, however, few
studies have considered its long-term effectiveness in routine services. This study
reports the outcomes of clients seen in a psychological therapies clinic, set up following
positive results obtained from an RCT (Peters et al., 2010). The aims were to evaluate
the effectiveness of CBTp, using data from the service’s routine assessments for
consecutive referrals over a 12 years period, and assess whether gains were maintained
at a 6+ months’ follow-up. Of the 476 consenting referrals, all clients (N = 358) who
received ≥5 therapy sessions were offered an assessment at four time points (baseline,
pre-, mid-, and end of therapy) on measures assessing current psychosis symptoms,
emotional problems, general well-being and life satisfaction. A sub-set (N = 113) was
assessed at a median of 12 months after finishing therapy. Following the waiting list
(median of 3 months) clients received individualized, formulation-based CBTp for a
median number of 19 sessions from 121 therapists with a range of experience receiving
regular supervision. Clients showed no meaningful change on any measure while on the
waiting list (Cohen’s d <= 0.23). In contrast, highly significant improvements following
therapy, all of which were significantly greater than changes during the waiting list, were
found on all domains assessed (Cohen’s d: 0.44–0.75). All gains were maintained at
follow-up (Cohen’s d: 0.29–0.82), with little change between end of therapy and follow-
up (Cohen’s d <= 0.18). Drop-out rate from therapy was low (13%). These results
demonstrate the positive and potentially enduring impact of psychological therapy on a
range of meaningful outcomes for clients with psychosis. The follow-up assessments
were conducted on only a sub-set, which may not generalize to the full sample.
Nevertheless this study is the largest of its kind in psychosis, and has important
implications for the practice of CBTp in clinical services.
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INTRODUCTION
Cognitive behavior therapy (CBT) for psychosis (CBTp) is an
adaptation of CBT for emotional disorders, tailored to the speciﬁc
needs of people with psychosis. The heterogeneity of presentation
in psychosis means that therapy approaches are diverse, with
up to 30 books and manuals currently available [see (Johns
et al., 2014) for a full list]. Broadly, the aims of CBTp are
to work collaboratively with the person to help them gain a
better understanding of their psychotic experiences and potential
contributing factors; enhance coping and improve functioning;
learn adaptive strategies to manage emotional distress; break
vicious cycles by identifying cognitive processes and behaviors
that are maintaining the problem; and consider alternative,
less distressing ways of appraising their experiences. The main
instrument of change in CBTp involves making changes in
appraisals and behavior to reduce distress, in the context of a
good therapeutic relationship.
There is now a robust evidence base demonstrating that
CBTp can produce improvements in a variety of outcomes in
patients who continue to have residual psychosis symptoms and
emotional diﬃculties despite optimal medication. This body of
work has led to its current status as a recommended treatment
within the UK National Institute for Health and Clinical
Excellence (NICE, 2014), American Patient Outcomes Research
Team (PORT; (Kreyenbuhl et al., 2010), and international
(Gaebel et al., 2011) guidelines for psychosis and schizophrenia.
To date, there have been 12 meta-analyses reviewing up to 50
randomised controlled trials (RCTs), including ﬁve within the
last year (Burns et al., 2014; Jauhar et al., 2014; Turner et al.,
2014; van der Gaag et al., 2014; Velthorst et al., 2015). The eﬀect
sizes across the diﬀerent meta-analyses are small to moderate,
ranging from 0.09 to 0.49, depending on trials included and
outcomes examined. Two of the larger meta-analyses reported
an inverse relationship between eﬀect size and methodological
rigor, especially blinding (Wykes et al., 2008; Jauhar et al., 2014),
suggesting caution in interpreting previous positive outcomes of
CBTp. However, the value of combining highly heterogeneous
trials with diﬀerent foci has been questioned (Byrne, 2014;
Peters, 2014), since such analyses reﬂect an over-simpliﬁcation
of the complexities of psychosis presentations and of the range
of psychological interventions encompassed within a broad
CBTp framework. Other recent meta-analyses, which focus
on treatment-resistant patients [eﬀect size: 0.47; (Burns et al.,
2014)], or on individually tailored, formulation-based CBT for
hallucinations (eﬀect size: 0.44) and delusions [eﬀect size: 0.36;
(van der Gaag et al., 2014)] are more informative about the
speciﬁc eﬀects of CBTp.
The focus on symptom severity as a primary outcome has also
been criticized, since CBTp targets symptom distress and impact
on functioning, as well as psychological recovery, rather than
symptom reduction per se (Birchwood and Trower, 2006). Trials
that have used ‘psychological’ outcomes rather than symptom
scores, such as compliance with command hallucinations
(Trower et al., 2004), global functioning (Grant et al., 2012),
or psychological well-being (Freeman et al., 2014), have tended
to report higher eﬀect sizes. Recent research has focused on
targeted therapies that evaluate individual components of therapy
focusing on speciﬁc processes, such as worry (Freeman et al.,
2015) or reasoning biases (Waller et al., 2011; Moritz et al., 2014;
Garety et al., 2015), or speciﬁc sub-populations such as psychosis
individuals presenting with command hallucinations (Birchwood
et al., 2014) or post-traumatic stress disorder (van den Berg et al.,
2015).
However, in clinical practice therapy tends to cover a range
of diﬃculties within the same individuals, including distressing
psychotic experiences, emotional problems, and quality of life.
In the UK, (NICE, 2014) recommend that therapy should be
formulation-based, and delivered on an individual basis for
at least 16 sessions over a period of six or more months.
While there are a number of obstacles in implementing NICE
guidance in practice (Berry and Haddock, 2008; Haddock et al.,
2014), nevertheless mental health services across the UK are
attempting to deliver CBTp routinely. To date, only a handful
of studies have evaluated CBTp delivered in routine clinical
services, mostly reporting eﬀectiveness RCTs (Farhall et al.,
2009; Peters et al., 2010; Lincoln et al., 2012). While RCTs
are clearly the gold standard in informing evidenced-based
practice, there are limitations that need to be considered when
inferring their eﬃcacy to real life clinical settings (Morrison
et al., 2004). RCTs, even those conducted as eﬀectiveness trials
within routine services, often have certain characteristics, such
as strict exclusion criteria and pre-deﬁned primary outcomes.
Furthermore, in routine services there is often a greater emphasis
on the goals of the individual client, causing variation in the
focus of therapy (Farhall et al., 2009). Therapists may diﬀer in
experience, profession and training levels, and there are often
limitations on time and resources.
There is a rich literature in other mental health disorders
on the need for ‘practice-based evidence,’ which contributes
in its own right to the evidence base for the eﬀectiveness of
psychological therapies (Lucock et al., 2003; Stiles et al., 2008).
For instance, (Ehlers et al., 2013) demonstrated that clinicians’
concerns that the good outcomes in eﬃcacy trials of CBT for
Post-Traumatic Stress Disorder (PTSD) would not generalize to
the wider range of traumas and presentations seen in routine
practice were not founded, with large improvements in PTSD
symptoms being observed in a consecutive sample attending a
psychological therapies clinic, and few of the selection criteria
used in RCTS moderating treatment outcome. In contrast,
(Quarmby et al., 2007) found that the outcomes for CBT for
chronic fatig syndrome in a routine service were inferior to those
found in a previous RCT, which the authors suggest may have
stemmed from patient selection, therapist factors and the use of a
manualised protocol in the RCT.
In psychosis the few naturalistic studies that have been carried
out have been highly promising (Thomas et al., 2011; Jolley
et al., 2015), although they have suﬀered from small sample
sizes. In a slightly larger study (N = 57; Morrison et al., 2004)
evaluated CBTp using non-expert therapists within a community
mental health team (CMHT) setting. CBTp produced signiﬁcant
improvements in positive symptoms, general mental health
problems, and depression, most of which were maintained at a
1-year follow-up. In the current study, we sought to extend this
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work by investigating the eﬀectiveness of CBTp on a range of
outcomes in a large, unselected consecutive sample attending a
psychological therapies service. (Peters et al., 2010) previously
reported positive outcomes on a number of variables in an
eﬀectiveness RCT conducted at the Psychological Interventions
Clinic for outpatients with Psychosis (PICuP), based at the
South London and Maudsley NHS Foundation Trust (SLaM),
some of which were maintained at follow-up. The current study
reports the outcomes of those patients seen in the clinical service,
developed from the trial, using data collected over a 12 years
period as part of the service’s routine assessments immediately
post therapy and at a minimum of 6 months’ follow-up.
MATERIALS AND METHODS
Service Setting
These data were collected at the Psychological Interventions
Clinic for outpatients with Psychosis (PICuP), part of the
Recovery Pathway of the SLaM Psychosis Clinical Academic
Group (CAG), based in South London at the Maudsley
Hospital, between 2003 and 2015. SLaM serves four London
boroughs, each with high rates of diversity [50–60% Black and
Minority Ethnic (BME) groups, Oﬃce for National Statistics,
2012], population movement, drug use, crime, socio-economic
deprivation, and psychosis incidence. A minority of patients
(<10%) were referred from other London and environs
boroughs. PICuP is a stand-alone psychological therapies clinic
oﬀering CBTp for outpatients with distressing positive symptoms
of psychosis, or with emotional diﬃculties in the context of
a history of psychosis. Therapists liaise closely with care-
coordinators in recovery multidisciplinary teams, but are not
part of the team, and do not prescribe medication or care-
coordinate/case-manage. PICuP was set-up as a National Health
Service (NHS) clinic on the back of initial funding for the RCT
(Peters et al., 2010), and has been running for 12 years.
Participants
The PICuPdatabase provided an initial sample of 510 consecutive
referrals whose therapy was completed and/or had been
discharged and/or whose follow-up period had elapsed. Thirty-
four people were excluded because they did not give consent
for their measures to be used for service evaluation purposes,
leaving 476 participants. The remaining sample consisted of
266 (56%) men and 210 (44%) women, with a mean age of
39 years (SD = 9.9). Almost half of the clients were from BME
groups (N = 205; 48%), and a substantial majority were single
(N = 340; 76%). Of the sample, 237 (50%) presented with current
auditory hallucinations, and 296 (62%) with delusions. 35% were
in the severe range for depression [>28 on the Beck Depression
Inventory-II; BDI-II (Beck et al., 1996)], and 38% for anxiety
[>25 on the Beck Anxiety Inventory (BAI; Beck et al., 1988)]1.
1There was one participant with missing data for age; 47 people did not wish to
disclose their ethnicity, and 29 did not reveal their marital status. There were 6
people with missing data on the PSYRATS-H, 4 on the PSYRATS-D, 123 on the
BDI, and 120 on the BAI (see section on measures for an explanation of the large
amount of missing data on BDI and BAI).
Measures
The assessments consisted of a battery of measures assessing
current symptoms of psychosis, emotional problems, and quality
of life. The choice of routine outcome measures selected by
the service is reﬂective of the wide range of problems held by
many clients attending PICuP, and the individualized nature of
therapy and people’s goals (Peters et al., 2010). The PSYRATs
scales (Haddock et al., 1999) were only administered to those
clients presenting with hallucinations (N = 237) and delusions
(N = 296). Pragmatic considerations typical of routine clinical
services, such as ﬁnancial constraints or Trust-wide initiatives,
led to the discontinuation of some measures after a number
of years (Beck Depression and Anxiety Inventories (Beck and
Steer, 1990; Beck et al., 1996); Manchester Short Assessment
of Quality of Life Questionnaire (MANSA; Priebe et al., 1999),
and the introduction of others [Clinical Outcomes in Routine
Evaluation-10 (CORE-10)] (Barkham et al., 2013).
Psychotic Symptom Rating Scales – Auditory
Hallucinations (PSYRATS-H; Haddock et al., 1999)
Eleven item semi-structured interview including frequency,
duration, location, loudness, beliefs about origin, negative
content, distress, disruption to life and control. Each symptom
is rated on a ﬁve-point ordinal scale (0–4) by the interviewer, and
the total scores range from 0–44.
Psychotic Symptom Rating Scales – Delusions
(PSYRATS-D; Haddock et al., 1999)
Six item semi-structured interview including preoccupation,
conviction, distress, and disruption to life. Each symptom is rated
on a ﬁve-point ordinal scale (0–4) by the interviewer, and the total
scores range from 0–24.
Beck Depression (BDI-II; Beck et al., 1996) and
Anxiety (BAI; Beck and Steer, 1990) Inventories
Twenty-one item self-report questionnaires assessing symptoms
of depression and anxiety, respectively, over the past week
(possible range 0–63).
Manchester Short Assessment of Quality of Life
Questionnaire (MANSA; Priebe et al., 1999)
Twelve item self-report questionnaire assessing satisfaction with
life as a whole and across various domains such as ﬁnances,
leisure, and mental health (possible range 0–84).
Clinical Outcomes in Routine Evaluation-10
(CORE-10; Barkham et al., 2013)
Ten-item self-report questionnaire assessing emotional well-
being. The CORE-10 generates a total distress score, based on
each item being rated from 0 to 4, with total scores ranging from
0 (low) to 40 (severe).
Therapy
All clients were oﬀered approximately 6–9 months of therapy,
although there was considerable variation across individuals in
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actual length of therapy received (median = 9; range = 3–342;
mode= 6). Overall 93% of the sample was seen for therapy within
an 18-month therapy window.
The median number of therapy sessions attended was 19
(mode = 26, range = 5–63). Number of sessions was highly
skewed, with only 13% receiving more than 26 sessions. While
clients were in therapy with PICuP they continued to receive
routine mental health care from their recovery team (such as
medication and appointments with care-coordinators), or their
General Practitioner (GP) if they had been discharged from their
team, but they did not receive other psychosocial interventions.
Therapy was usually delivered in weekly or fortnightly 1-hour
sessions, although again length of session was variable across
clients. All of the therapists (n = 121) had received training
in CBT but most were not experts in CBTp speciﬁcally. In
addition to permanent staﬀ and their clinical psychology trainees,
a large number of therapists were employed in other roles by
their NHS trust (e.g., clinical psychologist, psychiatrist, or nurse),
and conducted the therapy during their Continuous Professional
Development (CPD) sessions to develop their skills in CBTp.
All therapists attended fortnightly group supervision sessions
with a permanent senior member of staﬀ and had access to
a ‘therapy pack’ and a variety of reading materials. Clinical
psychology trainees received individual weekly supervision,
including listening to therapy tapes.
Therapy was conducted in a ﬂexible style with an emphasis
on engagement and building a good therapeutic relationship.
Interventions were formulation-based and focused on the
patient’s own goals, which, in addition to managing and
understanding distressing positive symptoms, often centered on
emotional problems and/or social inclusion (see Fowler et al.,
1995; Johns et al., 2014).
Procedure
Participants were assessed at four diﬀerent time points as part of
the routine outcome assessments for the clinic:
- Baseline (when ﬁrst referred to the service, before going on
the waiting list);
- Pre-therapy (just before starting therapy after having been
on the waiting list median of 3 months after the baseline
assessment (range 1–17 months; mode = 2);
- Mid-therapy (median of 4 months after the second or
baseline assessment (range 2–15 months; mode = 4);
- Post-therapy (within a few days or weeks of ﬁnishing
therapy; median of 5 months after the mid-therapy
assessment (range 1–25 months; mode = 5);
There were two exceptions to this: clients did not complete
the second assessment (pre-therapy) if the waiting list was
<=2 weeks, and the MANSA (Priebe et al., 1999) was only
administered at baseline and end of therapy assessments; both to
minimize client burden.
2Data on therapy duration were obtained from assessment dates; a few patients
were put on hold during the course of therapy, explaining the upper ranges of
therapy duration.
Seven years following the start of the service, a ﬁfth assessment
time-point was added:
- Follow-up (at a minimum of 6 months post therapy; median
12 months following end of therapy assessment, range 6–46,
mode = 6).
It was attempted to follow up early clients when the follow-
up assessments started to be implemented routinely, but only a
small percentage could be located; as a result the data-set for these
assessments is smaller than for the other time-points.
Outcomes at the mid-therapy assessment are not reported
here, but were included in the repeated measurements model in
order to further reduce potential bias created by missing values
(see statistical analysis section below).
Independent assessors (assistant psychologists trained in
administering all the measures) conducted the assessments.
Assessments lasted between 45 and 90 min, and could be
conducted over more than one session if necessary. Demographic
information from participants was collected at the baseline
assessment and from the standard ‘Patient Registration Form’
used by SLaM.
Statistical Analysis
The software packages STATA (version 11.2) and SPSS (version
21) were used to run the statistical analyses using a two-sided 1%
signiﬁcance level3.
The eﬀectiveness of CBTp was tested by the following
comparisons:
- Baseline vs. pre-therapy, to check stability of symptoms
while on the waiting list
- Pre-therapy vs. post-therapy, to assess change over the
course of therapy
- Change during waiting list (pre therapy – baseline) vs.
during therapy (post therapy – pre-therapy), to test whether
change was greater in the latter period than in the former
- Pre-therapy vs. follow-up, to assess whether any changes
were maintained +6 months following the end of therapy
- Post-therapy vs. follow-up, to check stability between end of
therapy and follow-up.
Longitudinal data were analyzed through repeated
measurement models (mixed eﬀects regression) by an
independent statistician (DA). For each outcome a linear
mixed model was run to compare the measurements at the ﬁve
time points (baseline; pre-therapy; mid-therapy; end of therapy;
and 6+ months follow-up), including all available data at each
time point.
The model, called covariance pattern model (Brown and
Prescott, 1996), analyses the repeated measurements nested
within individuals, using an unstructured covariance matrix
(which allows unequal variances and covariances between
the diﬀerent time points measures), under the missing data
assumption of missing at random (MAR, which does not depend
on the missing values being conditional on the observed data).
31% rather than 5% signiﬁcance level was used for all analyses to account for
multiple testing.
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In order to assess the ﬁve comparisons listed above, contrasts
were formally expressed and estimated using STATA’s ‘lincom’
function, and eﬀects sizes (Cohen’s d) for the changes of
interest were subsequently computed. Cohen’s d was calculated
by dividing the absolute mean change estimate by the standard
deviation of the mean baseline measure.
RESULTS
Therapy and Assessment Attrition
Attrition rates at each stage of assessment and therapy drop-
outs are illustrated in the service consort diagram (see Figure 1).
Clinical scores at each assessment stage (apart from mid-therapy)
on each of the six outcome measures are shown in Figure 2.
Of the 476 consenting cases, a further 118 people were
excluded from further assessments because they either did not
proceed to therapy [N = 78 (16%)], or they dropped out of
therapy too early to receive a meaningful ‘dose’ [deﬁned ‘a priori’
as attending fewer than ﬁve sessions4; N = 40 (8%)], according
to the clinic’s procedures. They did not diﬀer signiﬁcantly
from the 358 people who engaged in therapy (ﬁve or more
sessions attended) on gender (χ2 = 0.04, d.f. = 1, p > 0.1),
age (t = 1.6, d.f. = 473, p = 0.11), ethnicity (χ2 = 0.15,
d.f. = 1, p > 0.1), or marital status (χ2 = 3.07, d.f. = 3,
p> 0.1), or on any of the baseline clinical variables [PSYRATS–H
(Haddock et al., 1999): t = 0.11, d.f. = 235, p> 0.1; PSYRATS–D
(Haddock et al., 1999): t = 1.65, d.f. = 294, p = 0.10; BDI-
II (Beck et al., 1996): t = 2.25, d.f. = 351, p = 0.03; BAI
(Beck et al., 1988): t = 1.98, d.f. = 354, p = 0.05; CORE-10
(Barkham et al., 2013): t = 0.68, d.f. = 137, p> 0.1, and MANSA
(Priebe et al., 1999): t = 2.04, d.f. = 354, p = 0.05].
Of those who started therapy (398 people), 110 (28%) did
not complete a second assessment (either because they declined
or there was a therapist available within 2 weeks of baseline
assessment).
Of those who initially engaged in therapy (attended ﬁve or
more sessions; 358 people), 23 (5%) dropped out later on in
therapy, giving a total drop-out rate of 13% [i.e., including those
who did not engage (N = 40; 8%), and those who took up therapy
but later dropped out].
Of the 358 people who engaged in therapy, 73 (20%; 53
therapy completers and 20 drop-outs) declined an end of therapy
assessment, although 56% of them agreed to a mid-therapy
assessment (N = 36; 31 therapy completers and ﬁve drop-outs)
and/or a follow-up (N = 5; ﬁve therapy completers and zero
drop-out) assessment. Those who declined the end of therapy
assessment did not diﬀer signiﬁcantly from the 285 people who
completed it on gender (χ2 = 0.87, d.f. = 1, p > 0.1), age
(t = 1.5, d.f. = 355, p > 0.1), ethnicity (χ2 = 0.14, d.f. = 1,
p > 0.1), or marital status [χ2 = 5.7, d.f. = 3, p > 0.1)], or
on any of the baseline clinical variables [PSYRATS–H (Haddock
et al., 1999): t = 0.96, d.f. = 178, p> 0.1; PSYRATS–D (Haddock
et al., 1999): t = 1.38, d.f. = 237, p > 0.1; BDI-II (Beck et al.,
4<5 sessions was based on CBTp guidance that the ﬁrst 4–6 sessions are usually
devoted to engagement only.
1996): t = 0.41, d.f. = 271, p > 0.1; BAI (Beck et al., 1988):
t = 2.02, d.f. = 272, p = 0.05, CORE-10 (Barkham et al.,
2013): t = 1.23, d.f. = 105, p > 0.1, or MANSA (Priebe et al.,
1999): t = 2.31, d.f. = 281, p = 0.02].
A signiﬁcant number (N = 245; 68% of those who attended
ﬁve or more sessions) were lost to follow-up (see procedures
section). The 113 individuals who completed a 6+ months
follow-up assessment did not diﬀer from those who did not on
gender (χ2 = 3.0, d.f. = 1, p = 0.08), age (t = 0.59, d.f. = 355,
p > 0.1), ethnicity (χ2 = 0.4, d.f. = 1, p > 0.1), or marital
status (χ2 = 7.6, d.f. = 3, p = 0.06), or on any of the baseline
clinical variables [PSYRATS–H (Haddock et al., 1999): t = 0.10,
d.f. = 178, p > 0.1; PSYRATS–D (Haddock et al., 1999): t = 9.2,
d.f. = 237, p> 0.1;[BDI-II (Beck et al., 1996): t = 0.55, d.f. = 271,
p > 0.1; BAI (Beck et al., 1988): t = 1.4, d.f. = 272, p > 0.1),
CORE-10 (Barkham et al., 2013): t = 0.6, d.f. = 105, p > 0.1, or
MANSA (Priebe et al., 1999): t = 0.04, d.f. = 281, p> 0.1].
Furthermore, those who did not complete a follow-up
assessment did not diﬀer signiﬁcantly from those who did at the
end of therapy (or mid-therapy for those who did not complete
an end of therapy assessment) on any of the clinical variables
[PSYRATS–H (Haddock et al., 1999): t = 0.78, d.f. = 164,
p> 0.1; PSYRATS–D (Haddock et al., 1999): t = 0.34, d.f. = 219,
p > 0.1; BDI-II (Beck et al., 1996): t = 1.07, d.f. = 244, p > 0.1;
BAI (Beck et al., 1988): t = 1.26, d.f. = 245, p > 0.1, CORE-10
(Barkham et al., 2013): t = 1.72, d.f. = 118, p = 0.09, or MANSA
(Priebe et al., 1999): t = 0.71, d.f. = 216, p> 0.1].
Outcome Analyses
The residuals from the six diﬀerent linear models were
approximately normally distributed, denoting that the model
assumptions are plausible.
Results are displayed in Table 1. Total numbers available
for the six mixed-eﬀects regressions for each outcome were as
follows: PSYRATS-Voices = 248; PSYRATS-Delusions = 302;
BDI = 360; BAI = 362; CORE = 180; MANSA = 361. Results
are provided for the following contrasts: baseline vs. pre-therapy
(i.e., changes during the waiting list); pre- vs. post-therapy (i.e.,
changes during the therapy); pre-therapy vs. follow-up (i.e.,
changes during therapy + follow-up period); post-therapy vs.
follow-up (i.e., changes between the end of therapy and follow-
up). Finally the comparison between amount of change during
therapy and amount of change during waiting list is also reported.
It can be seen that clients’ symptoms remained stable during
the waiting list period, with all comparisons5 being either non-
signiﬁcant (voices; depression; anxiety; and well-being) or with
low eﬀect sizes (delusions; <=0.23). In contrast, all outcomes
improved signiﬁcantly after therapy (pre vs. post; all p < 0.001),
and were maintained at the follow-up stage (pre vs. follow-
up, also all p < 0.001), with eﬀect sizes ranging from 0.44
to 0.75 at the end of therapy, and 0.29 to 0.82 at follow-
up. Overall the eﬀect sizes for both comparisons were largest
for delusions, and smallest for anxiety. The change during
therapy (post therapy – pre-therapy) was signiﬁcantly greater
than that occurring during the waiting list (pre therapy –
5Quality of life (i.e., MANSA) data were not available for this comparison.
Frontiers in Psychology | www.frontiersin.org 5 October 2015 | Volume 6 | Article 1658
Peters et al. Long-term effectiveness of CBTp
baseline) on all available measures. There was little change
between end of therapy and follow-up, with all comparisons
either being non-signiﬁcant (voices; delusions; anxiety; well-
being; qualify of life) or with low eﬀect size (depression;
<=0.18), indicating that clients did not deteriorate following
the end of therapy, although they did not continue to improve
either.
DISCUSSION
In one of the largest eﬀectiveness study of its kind in psychosis,
we provide evidence for the long term eﬀectiveness of CBTp
on a range of meaningful outcomes, delivered in a UK, NHS
psychological therapies service. Bearing in mind that this
study reported on a consecutive sample with a wide range of
presentations from an ethnically diverse, socially deprived and
high mobility area; that drop-out rate from therapy was low
(13%); and that patients were seen by therapists with a wide range
of experience in CBTp, these results are encouraging. They add
support to the evidence-base from RCTs that suggests that people
who have ongoing, residual distressing symptoms of psychosis
and emotional diﬃculties represent one of the groups most likely
to beneﬁt from CBTp (Burns et al., 2014). They conﬁrm that
psychological well-being, emotional diﬃculties and quality of life
can also be improved by psychological therapy, in addition to
symptom-associated distress and disability.
Strengths
The results should be interpreted within the context of a number
of strengths and limitations. One of the strengths was the large
sample size, obtained from consecutive referrals over a 12 years
period. The sample was representative of the heterogeneity and
complexity of individuals presenting with psychotic symptoms,
unlike RCTs that have been criticized on the basis of ‘cherry-
picking’ their participants. As a service the PICuP clinic has
an inclusive suitability policy: referrals are deemed appropriate
FIGURE 1 | Consort diagram of closed cases.
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FIGURE 2 | Means (with standard errors) of clinical outcomes at each assessment time-point. PSYRATs, Psychotic Symptom Rating Scales (Haddock
et al., 1999). BDI-II and BAI, Beck Depression Inventory-II (Beck et al., 1996) and Beck Anxiety Inventory (Beck and Steer, 1990). CORE-10, Clinical Outcomes in
Routine Evaluation-10 (Barkham et al., 2013). MANSA, Manchester Short Assessment of Quality of Life Questionnaire (Priebe et al., 1999).
as long as people are presenting with distressing symptoms
of psychosis and/or emotional diﬃculties in the context of
a history of psychosis, and are willing and able to attend
sessions. We accept referrals with any diagnosis (or indeed
diagnostic conundrums), any type and severity of symptomatic
presentation, including co-morbidities, any type of medication
(or no medication), any level of cognitive ability, and any model
of understanding of psychotic experiences, i.e., having clinical
insight is not a pre-requisite. The only exclusion criteria are
a primary diagnosis of substance abuse (such as hallucinations
caused entirely by alcohol abuse), and a current, very high
risk of harming others. People who have a dual diagnosis with
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substance dependence, or are at risk of self-harm, are accepted
by the service. In practice, our service-users tend to be those
who do not need an assertive outreach service, i.e., they do not
have substantial negative symptoms and/or have predominantly
unmet social needs, and do not show severe chaotic behavior that
would prevent them from being able to attend any sessions.
Another important strength was the large number of
therapists (N = 121), most of whom were not expert in CBTp,
and included clinical psychologists in training. The relatively
large and enduring eﬀects show that this type of therapy can
be successfully implemented in an NHS setting with therapists
TABLE 1 | Mixed Effects Regression Results for the Effectiveness of CBTp.
Variable/Contrast Coefficient SE P-value Effect size
PSYRATS voices – Total (248 individuals)
Baseline vs. pre-therapy −0.46 0.57 0.42 0.05
Pre-therapy vs. post-therapy −4.65 0.83 <0.001 0.52
Change baseline/pre-therapy
vs. change pre/post-therapy∗
−4.18 1.20 <0.001
Pre-therapy vs. follow-up −3.89 1.05 <0.001 0.44
Post-therapy vs. follow-up 0.76 1.04 0.47 0.09
PSYRATS delusions – Total (302 individuals)
Baseline vs. pre-therapy −1.23 0.42 0.003 0.23
Pre-therapy vs. post-therapy −3.99 0.49 <0.001 0.75
Change baseline/pre-therapy
vs. change pre/post-therapy
−2.75 0.77 <0.001
Pre-therapy vs. follow-up −4.34 0.76 <0.001 0.82
Post-therapy vs. follow-up 0.35 0.70 0.61 0.07
BDI (360 individuals)
Baseline vs. pre-therapy −1.45 0.59 0.014 0.11
Pre-therapy vs. post-therapy −6.75 0.75 <0.001 0.51
Change baseline/pre-therapy
vs. change pre/post-therapy
−5.30 1.15 <0.001
Pre-therapy vs. follow-up −4.44 1.04 <0.001 0.34
Post-therapy vs. follow-up 2.31 0.91 0.01 0.18
BAI (362 individuals)
Baseline vs. pre-therapy −0.78 0.65 0.23 0.06
Pre-therapy vs. post-therapy −5.66 0.81 <0.001 0.44
Change baseline/pre-therapy
vs. change pre/post-therapy
−4.87 1.26 <0.001
Pre-therapy vs. follow-up −3.73 1.01 <0.001 0.29
Post-therapy vs. follow-up 1.93 0.95 0.04 0.15
CORE -Total (180 individuals)
Baseline vs. pre-therapy −1.42 0.67 0.03 0.17
Pre-therapy vs. post-therapy −5.18 0.72 <0.001 0.61
Change baseline/pre-therapy
vs. change pre/post-therapy
−3.76 1.20 <0.002
Pre-therapy vs. follow-up −3.95 0.90 <0.001 0.47
Post-therapy vs. follow-up 1.23 0.71 0.08 0.15
MANSA (361 individuals)
Pre-therapy vs. post-therapy 5.30 0.69 <0.001 0.49
Pre-therapy vs. follow-up 5.01 1.06 <0.001 0.47
Post-therapy vs. follow-up −0.29 0.92 0.75 0.03
∗ Is the change between pre vs. post-therapy significantly greater than the change
between baseline vs. second assessment?
Significant results (p < 0.01) in bold.
with a range of experience. However, similarly to our trial
(Peters et al., 2010), four crucial aspects of the therapy delivery
were likely to have facilitated good outcomes (see also Jolley
et al., 2015). First, all therapists had received training in CBT
already, and most had a doctoral qualiﬁcation (e.g., Doctorate
in Clinical Psychology), ensuring they were already familiar
with the cognitive model and general concepts of CBT, and
had some basic understanding of psychological approaches to
psychosis. Second, the service has a well-established supervision
structure, ensuring they all received regular clinical supervision
by senior staﬀ specializing in CBTp (fortnightly in a group
setting for qualiﬁed staﬀ, and individual weekly supervision for
trainees).
Third, PICuP is a stand-alone psychological therapies
service that operates independently from the referring teams,
although therapists liaise closely with the referrer about the
progress of their individual clients. This service context meant
that therapists had assured protected time for the delivery
of the therapy and attendance at supervision, free from
competing demands of multidisciplinary team work, whether
as permanent staﬀ in the PICuP clinic or as CPD therapists
employed in another setting. There is increasing evidence that
attempts to deliver complex therapies such as CBTp by care-
coordinators or staﬀ with limited training, or by adequately
trained therapists but without protected time or supervision,
are not likely to be productive (Brooker and Brabban, 2004;
Brosan et al., 2006; Steel et al., 2012). Finally, the specialized
nature of the service ensured both an awareness of how
to accommodate the diﬃculties facing people with psychosis
by all staﬀ, including assessors, as well as a predominant
culture embracing a psychological approach to psychosis (Cooke,
2014).
Further strengths included the use of independent assessors,
rather than outcomes being elicited by the therapists themselves,
and the availability of data from mid-therapy assessments for ﬁve
out of the six measures. The inclusion of mid-therapy outcomes
in the analyses meant that potential bias created by missing
values at the end of therapy assessment was reduced. Lastly the
follow-up period was of reasonable length (median of 12 months
post therapy), with the maximum being 46 months after having
ﬁnished therapy.
The PICuP service was set-up as part of a funded RCT
(Peters et al., 2010), and therefore its model of therapy
delivery and outcomes monitoring mirrored closely the high
standards of RCTs, which can be diﬃcult to achieve in routine
community services. However, it has been demonstrated
recently (Jolley et al., 2015) that this service model can be
implemented on a larger scale across diﬀerent pathways of
care [achieved with additional funding from NHS England for
the Improving Access to Psychological Therapies for Severe
Mental Illness (IAPT-SMI) initiative], with the important
variables being the employment of appropriately trained
therapists, access to regular supervision, protected time
to deliver therapy, and the use of independent assessors.
Whether this service model can be implemented in diﬀerent
health service contexts across countries remains to be
investigated.
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Limitations
The study also had limitations. The reported eﬀects are
within participants only, with no untreated or control therapy
group, and the results therefore cannot be unambiguously
interpreted as being due to the therapy. However, a number
of factors suggest that the reported beneﬁts are unlikely
to represent natural recovery. First, our sample consisted
largely of a fairly stable group with residual symptoms, rather
than an early intervention or frequently relapsing group;
in our trial the median length of illness was found to be
6.5 years (Peters et al., 2010). Second, no meaningful changes
were found on any of the measures used while patients
were on the waiting list, apart from a slight decrease in
delusions (eﬀect size = 0.23). Importantly, the diﬀerences in
outcomes between pre- and post-therapy assessments were
signiﬁcantly greater than those between baseline and pre-
therapy for all outcomes where this was available. It is
also unlikely that the results are due to natural ﬂuctuations
in symptoms, since outcomes remained stable both before
and following therapy, with the latter period being greater
(median of 12 months) than the length of therapy (median of
9 months).
The assessments were conducted by independent psychology
assistants, but they were not blind to the speciﬁc assessment
time-point, meaning that eﬀects may have been inﬂated by the
expectations of the assessors. However, four of the six measures
evaluated consisted of self-report, and would therefore not have
been subject to assessor bias; their eﬀect sizes were broadly
equivalent to those obtained from interviewer-rated measures.
A third limitation was that we had limited assessments on
those who dropped-out of therapy. Due to resource constraints
on the clinic, it was decided a-priori that those who did
not engage in therapy (i.e., attended fewer than ﬁve sessions)
would not be pursued for further assessments. Although it was
attempted to follow up those who engaged, but dropped out of
therapy at a later stage (i.e., attended ﬁve sessions or more), only
a minority agreed to be assessed (13%), although a further 20%
had mid-therapy data available. Nevertheless, once therapy was
started the number of drop-outs was low overall (13%: 8% did
not engage, and 5% dropped out at a later stage), and therefore
it is unlikely to have created a signiﬁcant bias in the overall
ﬁndings.
Although the overall sample size was large (number of cases
available for analyses ranged from 180 to 362, depending on
outcome), there were large amounts of missing data on some
scales, due to their intermittent use throughout the 12 years of
the service (due to ﬁnancial constraints or NHS Trust initiatives).
There was also a sizeable proportion (28%) who did not have
waiting list data due to missing assessments or immediate
allocation of a therapist.
Perhaps the most important limitation was that the follow-
up assessments were conducted on only a sub-set of the sample
who engaged in therapy (32%). This was partly because they were
only implemented as a routine procedure 7 years after the start
of the service, and partly because they tend to be de-prioritized
in a busy clinical setting. Although those who were followed-
up did not diﬀer on any demographic or clinical variable, either
at baseline or at the end of therapy, it remains unclear whether
loss to follow-up was random. It is possible that those who
feel they beneﬁted from therapy may be more willing to agree
to attend a follow-up assessment than others, thus creating a
possible bias toward an overestimate of treatment eﬀects at longer
term follow-up. On the other hand, it is also possible that some
people who are not doing well may be motivated to come back
for an assessment in order to access booster sessions (six booster
sessions are available to all those who request it). It is clearly
desirable to obtain a much higher follow-up rate, although this is
a diﬃcult task to achieve in the context of routine clinical services.
Overall it cannot be assumed that the long-term outcomes found
would generalize to the rest of the sample, and the ﬁndings
therefore have to be interpreted with this important caveat in
mind.
Other limitations included the lack of data available on
medication changes during therapy (or indeed any of the other
periods assessed), although in general this has not been found
to be a moderating factor in CBTp RCTs. Our sample may not
have been representative of all outpatients with psychosis; as a
psychological therapies service we are dependent on referrals
from other professionals (although a minority of our patients
also self-refer), and we tend not to see people with both socially
complex and chaotic presentations, who are better seen by
therapists working within multidisciplinary teams. This means
that our clients tend to be motivated to attend therapy, as is
illustrated by the low drop-out rate.
CONCLUSION
This study has important implications for the practice of CBTp.
It demonstrates that CBTp can have a positive impact on
clients’ experience of positive symptoms, levels of depression
and anxiety and overall well-being and satisfaction with their
life, even when conducted in a routine psychological therapies
service by CBT therapists with a range of experience in psychosis,
as long as people have regular supervision and protected
time. It also provides promising evidence that gains can be
maintained long-term, and opens the door for further research
to explore which aspects of CBTp have the most impact
long-term, and how we can aid the maintenance of therapy
gains.
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